SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Revance Therapeutics, Inc. – ‘10-Q’ for 9/30/15 – ‘EX-101.CAL’

On:  Tuesday, 11/10/15, at 5:11pm ET   ·   For:  9/30/15   ·   Accession #:  1479290-15-10   ·   File #:  1-36297

Previous ‘10-Q’:  ‘10-Q’ on 8/7/15 for 6/30/15   ·   Next:  ‘10-Q’ on 5/10/16 for 3/31/16   ·   Latest:  ‘10-Q’ on 11/8/23 for 9/30/23   ·   8 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

11/10/15  Revance Therapeutics, Inc.        10-Q        9/30/15   66:5.6M

Quarterly Report   —   Form 10-Q   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML    644K 
 2: EX-10.1     Material Contract                                   HTML     28K 
 3: EX-10.2     Material Contract                                   HTML     68K 
 4: EX-10.3     Material Contract                                   HTML     64K 
 5: EX-10.4     Material Contract                                   HTML     70K 
 6: EX-10.5     Material Contract                                   HTML     68K 
 7: EX-10.6     Material Contract                                   HTML     70K 
 8: EX-31.1     Certification -- §302 - SOA'02                      HTML     27K 
 9: EX-31.2     Certification -- §302 - SOA'02                      HTML     27K 
10: EX-32.1     Certification -- §906 - SOA'02                      HTML     23K 
11: EX-32.2     Certification -- §906 - SOA'02                      HTML     23K 
45: R1          Document and Entity Information                     HTML     39K 
35: R2          Condensed Consolidated Balance Sheets               HTML     99K 
43: R3          Condensed Consolidated Balance Sheets               HTML     31K 
                (Parenthetical)                                                  
48: R4          Condensed Consolidated Statement of Operations and  HTML     92K 
                Comprehensive Loss                                               
61: R5          Consolidated Statements of Cash Flows               HTML    171K 
37: R6          The Company and Basis of Presentation               HTML     36K 
42: R7          Summary of Significant Accounting Policies          HTML     39K 
32: R8          Medicis Settlement                                  HTML     30K 
25: R9          Cash Equivalents and Investments                    HTML     82K 
62: R10         Fair Value Measurements                             HTML     82K 
50: R11         Notes Payable and Financing Obligation              HTML     41K 
49: R12         Convertible Notes, Warrants, and Related            HTML     26K 
                Derivatives                                                      
54: R13         Interest Expense                                    HTML     62K 
55: R14         Commitments and Contingencies                       HTML     40K 
53: R15         Warrants                                            HTML     22K 
56: R16         Equity                                              HTML    105K 
44: R17         Net Loss per Share Attributable to Common           HTML     62K 
                Stockholders                                                     
46: R18         Subsequent Events                                   HTML     25K 
52: R19         Summary of Significant Accounting Policies          HTML     52K 
                (Policies)                                                       
66: R20         Cash Equivalents and Investments (Tables)           HTML     78K 
58: R21         Fair Value Measurements (Tables)                    HTML     79K 
39: R22         Notes Payable and Financing Obligation (Tables)     HTML     27K 
51: R23         Interest Expense (Tables)                           HTML     60K 
41: R24         Commitments and Contingencies (Tables)              HTML     28K 
22: R25         Equity (Tables)                                     HTML     92K 
59: R26         Net Loss per Share Attributable to Common           HTML     62K 
                Stockholders (Tables)                                            
63: R27         The Company and Basis of Presentation - Additional  HTML     60K 
                Information (Detail)                                             
28: R28         Medicis Settlement - Additional Information         HTML     49K 
                (Detail)                                                         
27: R29         Cash Equivalents and Investments (Details)          HTML     44K 
30: R30         Fair Value Measurements - Schedule of Fair Value    HTML     53K 
                of Financial Instruments (Detail)                                
31: R31         Fair Value Measurements - Summary of Changes in     HTML     27K 
                Fair Value of Financial Instruments (Detail)                     
33: R32         Notes Payable and Financing Obligation - Hercules   HTML     54K 
                Notes Payable (Detail)                                           
21: R33         Notes Payable and Financing Obligation - Essex      HTML     58K 
                Capital Notes (Detail)                                           
57: R34         Notes Payable and Financing Obligation - Summary    HTML     29K 
                of Aggregate Total Future Minimum Lease Payments                 
                under the Financing Obligation (Detail)                          
38: R35         Convertible Notes, Warrants, and Related            HTML     61K 
                Derivatives - Additional Information (Detail)                    
40: R36         Interest Expense - Summary of Interest Expense by   HTML     42K 
                Cash and Non-Cash Components (Detail)                            
24: R37         Commitments and Contingencies - Additional          HTML     34K 
                Information (Detail)                                             
65: R38         Commitments and Contingencies - Schedule of Future  HTML     38K 
                Minimum Lease Payments under Non-Cancelable                      
                Operating Leases (Detail)                                        
18: R39         Warrants - Additional Information (Detail)          HTML     28K 
34: R40         Equity - Additional Information (Detail)            HTML     69K 
60: R41         Equity - Fair Value Assumptions (Details)           HTML     44K 
23: R42         Equity - Schedule of Stock-based Compensation       HTML     30K 
                Expense (Details)                                                
26: R43         Equity - Schedule of Accumulated Other              HTML     33K 
                Comprehensive Income (Details)                                   
29: R44         Net Loss per Share Attributable to Common           HTML     45K 
                Stockholders - Schedule of Computation of Basic                  
                and Diluted Net Income (Loss) Per Share                          
                Attributable to Common Stockholders (Detail)                     
36: R45         Net Loss per Share Attributable to Common           HTML     34K 
                Stockholders - Summary of Common Stock Equivalents               
                Excluded from Computation of Diluted Net Income                  
                (Loss) Per Share (Detail)                                        
20: R46         Subsequent Events (Details)                         HTML     46K 
64: XML         IDEA XML File -- Filing Summary                      XML    106K 
19: EXCEL       IDEA Workbook of Financial Reports                  XLSX     58K 
12: EX-101.INS  XBRL Instance -- rvnc-20150930                       XML   1.30M 
14: EX-101.CAL  XBRL Calculations -- rvnc-20150930_cal               XML    173K 
15: EX-101.DEF  XBRL Definitions -- rvnc-20150930_def                XML    354K 
16: EX-101.LAB  XBRL Labels -- rvnc-20150930_lab                     XML   1.10M 
17: EX-101.PRE  XBRL Presentations -- rvnc-20150930_pre              XML    636K 
13: EX-101.SCH  XBRL Schema -- rvnc-20150930                         XSD    123K 
47: ZIP         XBRL Zipped Folder -- 0001479290-15-000010-xbrl      Zip    149K 


‘EX-101.CAL’   —   XBRL Calculations — rvnc-20150930_cal


This Exhibit is an XBRL XML File.


                                                                                                                                                                                
<?xml version="1.0" encoding="windows-1252"?>
<!-- XBRL Document Created with Wdesk from Workiva -->
<!-- -->
<linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<roleRef roleURI="http://www.revance.com/role/CashEquivalentsAndInvestments" xlink:href="rvnc-20150930.xsd#CashEquivalentsAndInvestments" xlink:type="simple"/>
<roleRef roleURI="http://www.revance.com/role/CashEquivalentsAndInvestmentsDetails" xlink:href="rvnc-20150930.xsd#CashEquivalentsAndInvestmentsDetails" xlink:type="simple"/>
<roleRef roleURI="http://www.revance.com/role/CashEquivalentsAndInvestmentsTables" xlink:href="rvnc-20150930.xsd#CashEquivalentsAndInvestmentsTables" xlink:type="simple"/>
<roleRef roleURI="http://www.revance.com/role/CommitmentsAndContingencies" xlink:href="rvnc-20150930.xsd#CommitmentsAndContingencies" xlink:type="simple"/>
<roleRef roleURI="http://www.revance.com/role/CommitmentsAndContingenciesAdditionalInformationDetail" xlink:href="rvnc-20150930.xsd#CommitmentsAndContingenciesAdditionalInformationDetail" xlink:type="simple"/>
<roleRef roleURI="http://www.revance.com/role/CommitmentsAndContingenciesScheduleOfFutureMinimumLeasePaymentsUnderNonCancelableOperatingLeasesDetail" xlink:href="rvnc-20150930.xsd#CommitmentsAndContingenciesScheduleOfFutureMinimumLeasePaymentsUnderNonCancelableOperatingLeasesDetail" xlink:type="simple"/>
<roleRef roleURI="http://www.revance.com/role/CommitmentsAndContingenciesTables" xlink:href="rvnc-20150930.xsd#CommitmentsAndContingenciesTables" xlink:type="simple"/>
<roleRef roleURI="http://www.revance.com/role/CompanyAndBasisOfPresentation" xlink:href="rvnc-20150930.xsd#CompanyAndBasisOfPresentation" xlink:type="simple"/>
<roleRef roleURI="http://www.revance.com/role/CompanyAndBasisOfPresentationAdditionalInformationDetail" xlink:href="rvnc-20150930.xsd#CompanyAndBasisOfPresentationAdditionalInformationDetail" xlink:type="simple"/>
<roleRef roleURI="http://www.revance.com/role/CondensedConsolidatedBalanceSheets" xlink:href="rvnc-20150930.xsd#CondensedConsolidatedBalanceSheets" xlink:type="simple"/>
<roleRef roleURI="http://www.revance.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:href="rvnc-20150930.xsd#CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="simple"/>
<roleRef roleURI="http://www.revance.com/role/CondensedConsolidatedStatementOfOperationsAndComprehensiveLoss" xlink:href="rvnc-20150930.xsd#CondensedConsolidatedStatementOfOperationsAndComprehensiveLoss" xlink:type="simple"/>
<roleRef roleURI="http://www.revance.com/role/ConsolidatedStatementsOfCashFlows" xlink:href="rvnc-20150930.xsd#ConsolidatedStatementsOfCashFlows" xlink:type="simple"/>
<roleRef roleURI="http://www.revance.com/role/ConvertibleNotesWarrantsAndRelatedDerivatives" xlink:href="rvnc-20150930.xsd#ConvertibleNotesWarrantsAndRelatedDerivatives" xlink:type="simple"/>
<roleRef roleURI="http://www.revance.com/role/ConvertibleNotesWarrantsAndRelatedDerivativesAdditionalInformationDetail" xlink:href="rvnc-20150930.xsd#ConvertibleNotesWarrantsAndRelatedDerivativesAdditionalInformationDetail" xlink:type="simple"/>
<roleRef roleURI="http://www.revance.com/role/DocumentAndEntityInformation" xlink:href="rvnc-20150930.xsd#DocumentAndEntityInformation" xlink:type="simple"/>
<roleRef roleURI="http://www.revance.com/role/Equity" xlink:href="rvnc-20150930.xsd#Equity" xlink:type="simple"/>
<roleRef roleURI="http://www.revance.com/role/EquityAdditionalInformationDetail" xlink:href="rvnc-20150930.xsd#EquityAdditionalInformationDetail" xlink:type="simple"/>
<roleRef roleURI="http://www.revance.com/role/EquityFairValueAssumptionsDetails" xlink:href="rvnc-20150930.xsd#EquityFairValueAssumptionsDetails" xlink:type="simple"/>
<roleRef roleURI="http://www.revance.com/role/EquityScheduleOfAccumulatedOtherComprehensiveIncomeDetails" xlink:href="rvnc-20150930.xsd#EquityScheduleOfAccumulatedOtherComprehensiveIncomeDetails" xlink:type="simple"/>
<roleRef roleURI="http://www.revance.com/role/EquityScheduleOfStockBasedCompensationExpenseDetails" xlink:href="rvnc-20150930.xsd#EquityScheduleOfStockBasedCompensationExpenseDetails" xlink:type="simple"/>
<roleRef roleURI="http://www.revance.com/role/EquityTables" xlink:href="rvnc-20150930.xsd#EquityTables" xlink:type="simple"/>
<roleRef roleURI="http://www.revance.com/role/FairValueMeasurements" xlink:href="rvnc-20150930.xsd#FairValueMeasurements" xlink:type="simple"/>
<roleRef roleURI="http://www.revance.com/role/FairValueMeasurementsScheduleOfFairValueOfFinancialInstrumentsDetail" xlink:href="rvnc-20150930.xsd#FairValueMeasurementsScheduleOfFairValueOfFinancialInstrumentsDetail" xlink:type="simple"/>
<roleRef roleURI="http://www.revance.com/role/FairValueMeasurementsSummaryOfChangesInFairValueOfFinancialInstrumentsDetail" xlink:href="rvnc-20150930.xsd#FairValueMeasurementsSummaryOfChangesInFairValueOfFinancialInstrumentsDetail" xlink:type="simple"/>
<roleRef roleURI="http://www.revance.com/role/FairValueMeasurementsTables" xlink:href="rvnc-20150930.xsd#FairValueMeasurementsTables" xlink:type="simple"/>
<roleRef roleURI="http://www.revance.com/role/InterestExpense" xlink:href="rvnc-20150930.xsd#InterestExpense" xlink:type="simple"/>
<roleRef roleURI="http://www.revance.com/role/InterestExpenseSummaryOfInterestExpenseByCashAndNonCashComponentsDetail" xlink:href="rvnc-20150930.xsd#InterestExpenseSummaryOfInterestExpenseByCashAndNonCashComponentsDetail" xlink:type="simple"/>
<roleRef roleURI="http://www.revance.com/role/InterestExpenseTables" xlink:href="rvnc-20150930.xsd#InterestExpenseTables" xlink:type="simple"/>
<roleRef roleURI="http://www.revance.com/role/MedicisSettlement" xlink:href="rvnc-20150930.xsd#MedicisSettlement" xlink:type="simple"/>
<roleRef roleURI="http://www.revance.com/role/MedicisSettlementAdditionalInformationDetail" xlink:href="rvnc-20150930.xsd#MedicisSettlementAdditionalInformationDetail" xlink:type="simple"/>
<roleRef roleURI="http://www.revance.com/role/NetLossPerShareAttributableToCommonStockholders" xlink:href="rvnc-20150930.xsd#NetLossPerShareAttributableToCommonStockholders" xlink:type="simple"/>
<roleRef roleURI="http://www.revance.com/role/NetLossPerShareAttributableToCommonStockholdersScheduleOfComputationOfBasicAndDilutedNetIncomeLossPerShareAttributableToCommonStockholdersDetail" xlink:href="rvnc-20150930.xsd#NetLossPerShareAttributableToCommonStockholdersScheduleOfComputationOfBasicAndDilutedNetIncomeLossPerShareAttributableToCommonStockholdersDetail" xlink:type="simple"/>
<roleRef roleURI="http://www.revance.com/role/NetLossPerShareAttributableToCommonStockholdersSummaryOfCommonStockEquivalentsExcludedFromComputationOfDilutedNetIncomeLossPerShareDetail" xlink:href="rvnc-20150930.xsd#NetLossPerShareAttributableToCommonStockholdersSummaryOfCommonStockEquivalentsExcludedFromComputationOfDilutedNetIncomeLossPerShareDetail" xlink:type="simple"/>
<roleRef roleURI="http://www.revance.com/role/NetLossPerShareAttributableToCommonStockholdersTables" xlink:href="rvnc-20150930.xsd#NetLossPerShareAttributableToCommonStockholdersTables" xlink:type="simple"/>
<roleRef roleURI="http://www.revance.com/role/NotesPayableAndFinancingObligation" xlink:href="rvnc-20150930.xsd#NotesPayableAndFinancingObligation" xlink:type="simple"/>
<roleRef roleURI="http://www.revance.com/role/NotesPayableAndFinancingObligationEssexCapitalNotesDetail" xlink:href="rvnc-20150930.xsd#NotesPayableAndFinancingObligationEssexCapitalNotesDetail" xlink:type="simple"/>
<roleRef roleURI="http://www.revance.com/role/NotesPayableAndFinancingObligationHerculesNotesPayableDetail" xlink:href="rvnc-20150930.xsd#NotesPayableAndFinancingObligationHerculesNotesPayableDetail" xlink:type="simple"/>
<roleRef roleURI="http://www.revance.com/role/NotesPayableAndFinancingObligationSummaryOfAggregateTotalFutureMinimumLeasePaymentsUnderFinancingObligationDetail" xlink:href="rvnc-20150930.xsd#NotesPayableAndFinancingObligationSummaryOfAggregateTotalFutureMinimumLeasePaymentsUnderFinancingObligationDetail" xlink:type="simple"/>
<roleRef roleURI="http://www.revance.com/role/NotesPayableAndFinancingObligationTables" xlink:href="rvnc-20150930.xsd#NotesPayableAndFinancingObligationTables" xlink:type="simple"/>
<roleRef roleURI="http://www.revance.com/role/SubsequentEvents" xlink:href="rvnc-20150930.xsd#SubsequentEvents" xlink:type="simple"/>
<roleRef roleURI="http://www.revance.com/role/SubsequentEventsDetails" xlink:href="rvnc-20150930.xsd#SubsequentEventsDetails" xlink:type="simple"/>
<roleRef roleURI="http://www.revance.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="rvnc-20150930.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple"/>
<roleRef roleURI="http://www.revance.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="rvnc-20150930.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple"/>
<roleRef roleURI="http://www.revance.com/role/Warrants" xlink:href="rvnc-20150930.xsd#Warrants" xlink:type="simple"/>
<roleRef roleURI="http://www.revance.com/role/WarrantsAdditionalInformationDetail" xlink:href="rvnc-20150930.xsd#WarrantsAdditionalInformationDetail" xlink:type="simple"/>
<calculationLink xlink:role="http://www.revance.com/role/CashEquivalentsAndInvestments" xlink:type="extended"/>
<calculationLink xlink:role="http://www.revance.com/role/CashEquivalentsAndInvestmentsDetails" xlink:type="extended">
<loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AvailableForSaleSecuritiesAmortizedCost" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesAmortizedCost_fc1c6482-bc06-c49d-f5fe-3b9e6e37b9c3" xlink:type="locator"/>
<loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_d5cbedb3-d62c-f015-a49f-ef377e438819" xlink:type="locator"/>
<calculationArc order="1" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAmortizedCost_fc1c6482-bc06-c49d-f5fe-3b9e6e37b9c3" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_d5cbedb3-d62c-f015-a49f-ef377e438819" xlink:type="arc"/>
<loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_258c41aa-2b09-923b-df97-cb86ef48f935" xlink:type="locator"/>
<calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAmortizedCost_fc1c6482-bc06-c49d-f5fe-3b9e6e37b9c3" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_258c41aa-2b09-923b-df97-cb86ef48f935" xlink:type="arc"/>
<loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AvailableForSaleSecurities" xlink:label="loc_us-gaap_AvailableForSaleSecurities_a6e76a34-fa42-d66f-a2a4-5865ce92446b" xlink:type="locator"/>
<calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAmortizedCost_fc1c6482-bc06-c49d-f5fe-3b9e6e37b9c3" xlink:to="loc_us-gaap_AvailableForSaleSecurities_a6e76a34-fa42-d66f-a2a4-5865ce92446b" xlink:type="arc"/>
</calculationLink>
<calculationLink xlink:role="http://www.revance.com/role/CashEquivalentsAndInvestmentsTables" xlink:type="extended"/>
<calculationLink xlink:role="http://www.revance.com/role/CommitmentsAndContingencies" xlink:type="extended"/>
<calculationLink xlink:role="http://www.revance.com/role/CommitmentsAndContingenciesAdditionalInformationDetail" xlink:type="extended"/>
<calculationLink xlink:role="http://www.revance.com/role/CommitmentsAndContingenciesScheduleOfFutureMinimumLeasePaymentsUnderNonCancelableOperatingLeasesDetail" xlink:type="extended">
<loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDue_6282e4c0-b0bd-9c84-bf43-857ac02b98fc" xlink:type="locator"/>
<loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_8a0692b4-cb50-1eeb-12b4-1509099841b7" xlink:type="locator"/>
<calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDue_6282e4c0-b0bd-9c84-bf43-857ac02b98fc" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_8a0692b4-cb50-1eeb-12b4-1509099841b7" xlink:type="arc"/>
<loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_4c8190eb-f692-81f2-35bc-182f11d12444" xlink:type="locator"/>
<calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDue_6282e4c0-b0bd-9c84-bf43-857ac02b98fc" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_4c8190eb-f692-81f2-35bc-182f11d12444" xlink:type="arc"/>
<loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_baee32aa-bbe2-ead3-1f78-a80f542a97a2" xlink:type="locator"/>
<calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDue_6282e4c0-b0bd-9c84-bf43-857ac02b98fc" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_baee32aa-bbe2-ead3-1f78-a80f542a97a2" xlink:type="arc"/>
<loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_5e342c11-473b-4170-d672-935adcfdb463" xlink:type="locator"/>
<calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDue_6282e4c0-b0bd-9c84-bf43-857ac02b98fc" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_5e342c11-473b-4170-d672-935adcfdb463" xlink:type="arc"/>
<loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter_6adcb5b9-fb65-97ee-8a5b-2e780c178728" xlink:type="locator"/>
<calculationArc order="5" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDue_6282e4c0-b0bd-9c84-bf43-857ac02b98fc" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter_6adcb5b9-fb65-97ee-8a5b-2e780c178728" xlink:type="arc"/>
</calculationLink>
<calculationLink xlink:role="http://www.revance.com/role/CommitmentsAndContingenciesTables" xlink:type="extended"/>
<calculationLink xlink:role="http://www.revance.com/role/CompanyAndBasisOfPresentation" xlink:type="extended"/>
<calculationLink xlink:role="http://www.revance.com/role/CompanyAndBasisOfPresentationAdditionalInformationDetail" xlink:type="extended"/>
<calculationLink xlink:role="http://www.revance.com/role/CondensedConsolidatedBalanceSheets" xlink:type="extended">
<loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets_effc14df-fd72-eec8-ede9-64e0071b91bc" xlink:type="locator"/>
<loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaap_AssetsCurrent_39eaeb62-7ee3-5503-48f5-08c2dff05e50" xlink:type="locator"/>
<calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_effc14df-fd72-eec8-ede9-64e0071b91bc" xlink:to="loc_us-gaap_AssetsCurrent_39eaeb62-7ee3-5503-48f5-08c2dff05e50" xlink:type="arc"/>
<loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_cd34decb-53b6-e0a9-28d5-0a9741c4b0f8" xlink:type="locator"/>
<calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_39eaeb62-7ee3-5503-48f5-08c2dff05e50" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_cd34decb-53b6-e0a9-28d5-0a9741c4b0f8" xlink:type="arc"/>
<loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_f186537c-a0b4-9ca7-f59a-958a18f111e6" xlink:type="locator"/>
<calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_39eaeb62-7ee3-5503-48f5-08c2dff05e50" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_f186537c-a0b4-9ca7-f59a-958a18f111e6" xlink:type="arc"/>
<loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShortTermInvestments" xlink:label="loc_us-gaap_ShortTermInvestments_777309da-a5d9-d5ab-d632-48c8a96679c2" xlink:type="locator"/>
<calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_39eaeb62-7ee3-5503-48f5-08c2dff05e50" xlink:to="loc_us-gaap_ShortTermInvestments_777309da-a5d9-d5ab-d632-48c8a96679c2" xlink:type="arc"/>
<loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_05676487-dc23-faad-ff63-cd1ae2cdcbac" xlink:type="locator"/>
<calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_39eaeb62-7ee3-5503-48f5-08c2dff05e50" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_05676487-dc23-faad-ff63-cd1ae2cdcbac" xlink:type="arc"/>
<loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_7ce178a4-245f-fa78-36a1-552609a67554" xlink:type="locator"/>
<calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_effc14df-fd72-eec8-ede9-64e0071b91bc" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_7ce178a4-245f-fa78-36a1-552609a67554" xlink:type="arc"/>
<loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsNoncurrent" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent_0565982a-103e-d759-dc77-3972f0ce1b3e" xlink:type="locator"/>
<calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_effc14df-fd72-eec8-ede9-64e0071b91bc" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent_0565982a-103e-d759-dc77-3972f0ce1b3e" xlink:type="arc"/>
<loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_9b98e689-e6db-3e5b-e5c3-3324fffb4edf" xlink:type="locator"/>
<calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_effc14df-fd72-eec8-ede9-64e0071b91bc" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_9b98e689-e6db-3e5b-e5c3-3324fffb4edf" xlink:type="arc"/>
<loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LongTermInvestments" xlink:label="loc_us-gaap_LongTermInvestments_27d14e42-ada3-42c7-e1aa-70cd856fa1fe" xlink:type="locator"/>
<calculationArc order="5" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_effc14df-fd72-eec8-ede9-64e0071b91bc" xlink:to="loc_us-gaap_LongTermInvestments_27d14e42-ada3-42c7-e1aa-70cd856fa1fe" xlink:type="arc"/>
<loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_4a314f0d-c6fa-5cf2-0be1-add747465af3" xlink:type="locator"/>
<loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaap_Liabilities_4e70462c-e5f6-e2d9-0cf5-7f1332ddbc05" xlink:type="locator"/>
<calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_4a314f0d-c6fa-5cf2-0be1-add747465af3" xlink:to="loc_us-gaap_Liabilities_4e70462c-e5f6-e2d9-0cf5-7f1332ddbc05" xlink:type="arc"/>
<loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaap_LiabilitiesCurrent_1de50dbc-01a9-6657-f83f-d1e74edfdf18" xlink:type="locator"/>
<calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_4e70462c-e5f6-e2d9-0cf5-7f1332ddbc05" xlink:to="loc_us-gaap_LiabilitiesCurrent_1de50dbc-01a9-6657-f83f-d1e74edfdf18" xlink:type="arc"/>
<loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaap_AccountsPayableCurrent_22caddf9-3843-6329-6e39-dc458323b572" xlink:type="locator"/>
<calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_1de50dbc-01a9-6657-f83f-d1e74edfdf18" xlink:to="loc_us-gaap_AccountsPayableCurrent_22caddf9-3843-6329-6e39-dc458323b572" xlink:type="arc"/>
<loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_eaf92fb1-642d-2c65-5ba7-1a63a3697f47" xlink:type="locator"/>
<calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_1de50dbc-01a9-6657-f83f-d1e74edfdf18" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_eaf92fb1-642d-2c65-5ba7-1a63a3697f47" xlink:type="arc"/>
<loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NotesPayableCurrent" xlink:label="loc_us-gaap_NotesPayableCurrent_5a2950e7-c6e8-35c1-e326-1fa3d204c436" xlink:type="locator"/>
<calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_1de50dbc-01a9-6657-f83f-d1e74edfdf18" xlink:to="loc_us-gaap_NotesPayableCurrent_5a2950e7-c6e8-35c1-e326-1fa3d204c436" xlink:type="arc"/>
<loc xlink:href="rvnc-20150930.xsd#rvnc_FinancingObligationCurrent" xlink:label="loc_rvnc_FinancingObligationCurrent_ff549a2f-5078-d78a-c911-b51778426773" xlink:type="locator"/>
<calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_1de50dbc-01a9-6657-f83f-d1e74edfdf18" xlink:to="loc_rvnc_FinancingObligationCurrent_ff549a2f-5078-d78a-c911-b51778426773" xlink:type="arc"/>
<loc xlink:href="rvnc-20150930.xsd#rvnc_FinancingLeaseObligationNoncurrentNetofCurrentPortion" xlink:label="loc_rvnc_FinancingLeaseObligationNoncurrentNetofCurrentPortion_fdf30093-fae4-f7fa-f5d3-b5177836ec6a" xlink:type="locator"/>
<calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_4e70462c-e5f6-e2d9-0cf5-7f1332ddbc05" xlink:to="loc_rvnc_FinancingLeaseObligationNoncurrentNetofCurrentPortion_fdf30093-fae4-f7fa-f5d3-b5177836ec6a" xlink:type="arc"/>
<loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DerivativeLiabilitiesNoncurrent" xlink:label="loc_us-gaap_DerivativeLiabilitiesNoncurrent_7a1d530e-b8a4-9676-69c4-b6a34f24491d" xlink:type="locator"/>
<calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_4e70462c-e5f6-e2d9-0cf5-7f1332ddbc05" xlink:to="loc_us-gaap_DerivativeLiabilitiesNoncurrent_7a1d530e-b8a4-9676-69c4-b6a34f24491d" xlink:type="arc"/>
<loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredRentCreditNoncurrent" xlink:label="loc_us-gaap_DeferredRentCreditNoncurrent_837ff1b5-f4a9-6226-286b-ca7e18b0c168" xlink:type="locator"/>
<calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_4e70462c-e5f6-e2d9-0cf5-7f1332ddbc05" xlink:to="loc_us-gaap_DeferredRentCreditNoncurrent_837ff1b5-f4a9-6226-286b-ca7e18b0c168" xlink:type="arc"/>
<loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_d0f349aa-18e3-6323-86ad-665f8773c064" xlink:type="locator"/>
<calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_4a314f0d-c6fa-5cf2-0be1-add747465af3" xlink:to="loc_us-gaap_StockholdersEquity_d0f349aa-18e3-6323-86ad-665f8773c064" xlink:type="arc"/>
<loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaap_CommonStockValue_ce40a301-9b6b-9fc3-bfb6-dfbb8fcdf29b" xlink:type="locator"/>
<calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_d0f349aa-18e3-6323-86ad-665f8773c064" xlink:to="loc_us-gaap_CommonStockValue_ce40a301-9b6b-9fc3-bfb6-dfbb8fcdf29b" xlink:type="arc"/>
<loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_8d1ec446-d346-e57d-d34b-0cb90bceaaba" xlink:type="locator"/>
<calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_d0f349aa-18e3-6323-86ad-665f8773c064" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_8d1ec446-d346-e57d-d34b-0cb90bceaaba" xlink:type="arc"/>
<loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_dd6b7206-c19f-4dd5-339b-1369c57cfe0f" xlink:type="locator"/>
<calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_d0f349aa-18e3-6323-86ad-665f8773c064" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_dd6b7206-c19f-4dd5-339b-1369c57cfe0f" xlink:type="arc"/>
<loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_1d565cd0-d7bf-de89-4dbe-a484007b1fe8" xlink:type="locator"/>
<calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_d0f349aa-18e3-6323-86ad-665f8773c064" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_1d565cd0-d7bf-de89-4dbe-a484007b1fe8" xlink:type="arc"/>
<loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaap_CommitmentsAndContingencies_53d4115f-c3d1-6e9c-3f23-fd144b27061e" xlink:type="locator"/>
<calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_4a314f0d-c6fa-5cf2-0be1-add747465af3" xlink:to="loc_us-gaap_CommitmentsAndContingencies_53d4115f-c3d1-6e9c-3f23-fd144b27061e" xlink:type="arc"/>
</calculationLink>
<calculationLink xlink:role="http://www.revance.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="extended"/>
<calculationLink xlink:role="http://www.revance.com/role/CondensedConsolidatedStatementOfOperationsAndComprehensiveLoss" xlink:type="extended">
<loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_640557c9-9806-6bef-9084-9cc792948f77" xlink:type="locator"/>
<loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_e62ce8b8-4401-2622-8598-3e644745e95e" xlink:type="locator"/>
<calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_640557c9-9806-6bef-9084-9cc792948f77" xlink:to="loc_us-gaap_NetIncomeLoss_e62ce8b8-4401-2622-8598-3e644745e95e" xlink:type="arc"/>
<loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaap_OperatingIncomeLoss_0ea1551e-1643-5e21-4c6e-6431fd87aa68" xlink:type="locator"/>
<calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_e62ce8b8-4401-2622-8598-3e644745e95e" xlink:to="loc_us-gaap_OperatingIncomeLoss_0ea1551e-1643-5e21-4c6e-6431fd87aa68" xlink:type="arc"/>
<loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaap_OperatingExpenses_8d80f9f2-ec8e-5a02-2390-b5ea959a18b0" xlink:type="locator"/>
<calculationArc order="1" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_0ea1551e-1643-5e21-4c6e-6431fd87aa68" xlink:to="loc_us-gaap_OperatingExpenses_8d80f9f2-ec8e-5a02-2390-b5ea959a18b0" xlink:type="arc"/>
<loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_6a3cb05a-f9c0-32f6-d20f-a948f53d0ee5" xlink:type="locator"/>
<calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_8d80f9f2-ec8e-5a02-2390-b5ea959a18b0" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_6a3cb05a-f9c0-32f6-d20f-a948f53d0ee5" xlink:type="arc"/>
<loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_37d23128-e0be-7b8b-d6c6-f3d1ac14cac9" xlink:type="locator"/>
<calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_8d80f9f2-ec8e-5a02-2390-b5ea959a18b0" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_37d23128-e0be-7b8b-d6c6-f3d1ac14cac9" xlink:type="arc"/>
<loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaap_Revenues_ba59260a-e348-d7f8-5375-fde11baf79c1" xlink:type="locator"/>
<calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_0ea1551e-1643-5e21-4c6e-6431fd87aa68" xlink:to="loc_us-gaap_Revenues_ba59260a-e348-d7f8-5375-fde11baf79c1" xlink:type="arc"/>
<loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InvestmentIncomeNonoperating" xlink:label="loc_us-gaap_InvestmentIncomeNonoperating_ee092447-74b9-bdb7-7519-e38b0e5f4508" xlink:type="locator"/>
<calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_e62ce8b8-4401-2622-8598-3e644745e95e" xlink:to="loc_us-gaap_InvestmentIncomeNonoperating_ee092447-74b9-bdb7-7519-e38b0e5f4508" xlink:type="arc"/>
<loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaap_InterestExpense_8d3aa4ad-dbea-9eba-4578-5d3b83ba3bc6" xlink:type="locator"/>
<calculationArc order="3" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_e62ce8b8-4401-2622-8598-3e644745e95e" xlink:to="loc_us-gaap_InterestExpense_8d3aa4ad-dbea-9eba-4578-5d3b83ba3bc6" xlink:type="arc"/>
<loc xlink:href="rvnc-20150930.xsd#rvnc_GainLossonDerivativeInstrumentsContractNetPretax" xlink:label="loc_rvnc_GainLossonDerivativeInstrumentsContractNetPretax_e1594837-02fc-96bc-26c9-b5177841c36c" xlink:type="locator"/>
<calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_e62ce8b8-4401-2622-8598-3e644745e95e" xlink:to="loc_rvnc_GainLossonDerivativeInstrumentsContractNetPretax_e1594837-02fc-96bc-26c9-b5177841c36c" xlink:type="arc"/>
<loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="loc_us-gaap_FairValueAdjustmentOfWarrants_62790e96-2cfd-e84e-131c-ca4fa0c495e1" xlink:type="locator"/>
<calculationArc order="5" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_e62ce8b8-4401-2622-8598-3e644745e95e" xlink:to="loc_us-gaap_FairValueAdjustmentOfWarrants_62790e96-2cfd-e84e-131c-ca4fa0c495e1" xlink:type="arc"/>
<loc xlink:href="rvnc-20150930.xsd#rvnc_ChangeinFairValueofConvertiblePreferredStockWarrant" xlink:label="loc_rvnc_ChangeinFairValueofConvertiblePreferredStockWarrant_88a94cba-33fa-f4fd-0801-b5177822c5cc" xlink:type="locator"/>
<calculationArc order="6" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_e62ce8b8-4401-2622-8598-3e644745e95e" xlink:to="loc_rvnc_ChangeinFairValueofConvertiblePreferredStockWarrant_88a94cba-33fa-f4fd-0801-b5177822c5cc" xlink:type="arc"/>
<loc xlink:href="rvnc-20150930.xsd#rvnc_GainLossOnSettlementInExchangeOfPreferredStockWarrants" xlink:label="loc_rvnc_GainLossOnSettlementInExchangeOfPreferredStockWarrants_096fb9cb-c9bd-3740-2c5e-b51777ec83d0" xlink:type="locator"/>
<calculationArc order="7" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_e62ce8b8-4401-2622-8598-3e644745e95e" xlink:to="loc_rvnc_GainLossOnSettlementInExchangeOfPreferredStockWarrants_096fb9cb-c9bd-3740-2c5e-b51777ec83d0" xlink:type="arc"/>
<loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_51486ac3-3cfb-dff4-43ca-0d3980775a1d" xlink:type="locator"/>
<calculationArc order="8" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_e62ce8b8-4401-2622-8598-3e644745e95e" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_51486ac3-3cfb-dff4-43ca-0d3980775a1d" xlink:type="arc"/>
<loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_GainLossOnDerivativeInstrumentsNetPretax" xlink:label="loc_us-gaap_GainLossOnDerivativeInstrumentsNetPretax_aa1c1d3a-3c5f-1416-a988-644e94e86c05" xlink:type="locator"/>
<calculationArc order="9" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_e62ce8b8-4401-2622-8598-3e644745e95e" xlink:to="loc_us-gaap_GainLossOnDerivativeInstrumentsNetPretax_aa1c1d3a-3c5f-1416-a988-644e94e86c05" xlink:type="arc"/>
<loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGains" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGains_117db509-2aee-fd73-862e-1e833502691a" xlink:type="locator"/>
<calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_640557c9-9806-6bef-9084-9cc792948f77" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGains_117db509-2aee-fd73-862e-1e833502691a" xlink:type="arc"/>
</calculationLink>
<calculationLink xlink:role="http://www.revance.com/role/ConsolidatedStatementsOfCashFlows" xlink:type="extended">
<loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_ff5db18e-7b91-5a5d-e914-0527b02a8012" xlink:type="locator"/>
<loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_a678c20d-a481-ef6a-800a-4bd566075d81" xlink:type="locator"/>
<calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_ff5db18e-7b91-5a5d-e914-0527b02a8012" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_a678c20d-a481-ef6a-800a-4bd566075d81" xlink:type="arc"/>
<loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:label="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_51bf3d69-2a89-19f4-d615-2af819fdbb35" xlink:type="locator"/>
<calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_a678c20d-a481-ef6a-800a-4bd566075d81" xlink:to="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_51bf3d69-2a89-19f4-d615-2af819fdbb35" xlink:type="arc"/>
<loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProceedsFromNotesPayable" xlink:label="loc_us-gaap_ProceedsFromNotesPayable_ae38354d-77f5-8db7-0abd-f1fc628a19a0" xlink:type="locator"/>
<calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_a678c20d-a481-ef6a-800a-4bd566075d81" xlink:to="loc_us-gaap_ProceedsFromNotesPayable_ae38354d-77f5-8db7-0abd-f1fc628a19a0" xlink:type="arc"/>
<loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities_916c0ad8-4410-ac61-854a-bcef2cfe3ffc" xlink:type="locator"/>
<calculationArc order="3" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_a678c20d-a481-ef6a-800a-4bd566075d81" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities_916c0ad8-4410-ac61-854a-bcef2cfe3ffc" xlink:type="arc"/>
<loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_2660b777-f313-aa0f-f2f0-b727ebbc5b13" xlink:type="locator"/>
<calculationArc order="4" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_a678c20d-a481-ef6a-800a-4bd566075d81" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_2660b777-f313-aa0f-f2f0-b727ebbc5b13" xlink:type="arc"/>
<loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:label="loc_us-gaap_RepaymentsOfNotesPayable_e62f836f-8946-6184-26d1-70135f5dd38d" xlink:type="locator"/>
<calculationArc order="5" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_a678c20d-a481-ef6a-800a-4bd566075d81" xlink:to="loc_us-gaap_RepaymentsOfNotesPayable_e62f836f-8946-6184-26d1-70135f5dd38d" xlink:type="arc"/>
<loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SaleLeasebackTransactionNetProceedsFinancingActivities" xlink:label="loc_us-gaap_SaleLeasebackTransactionNetProceedsFinancingActivities_e44a791f-c26f-d65e-b580-5453ba592786" xlink:type="locator"/>
<calculationArc order="6" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_a678c20d-a481-ef6a-800a-4bd566075d81" xlink:to="loc_us-gaap_SaleLeasebackTransactionNetProceedsFinancingActivities_e44a791f-c26f-d65e-b580-5453ba592786" xlink:type="arc"/>
<loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_f1b85fa1-97cd-57cc-5318-fb8dd976eb81" xlink:type="locator"/>
<calculationArc order="7" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_a678c20d-a481-ef6a-800a-4bd566075d81" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_f1b85fa1-97cd-57cc-5318-fb8dd976eb81" xlink:type="arc"/>
<loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PaymentsForRepurchaseOfWarrants" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfWarrants_04408b61-53bd-d4ec-5612-efaa826b08f4" xlink:type="locator"/>
<calculationArc order="8" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_a678c20d-a481-ef6a-800a-4bd566075d81" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfWarrants_04408b61-53bd-d4ec-5612-efaa826b08f4" xlink:type="arc"/>
<loc xlink:href="rvnc-20150930.xsd#rvnc_ProceedsFromIssuanceofFollowOnOffering" xlink:label="loc_rvnc_ProceedsFromIssuanceofFollowOnOffering_9b2ae8cb-8c23-47d9-667a-b51777eb7c88" xlink:type="locator"/>
<calculationArc order="9" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_a678c20d-a481-ef6a-800a-4bd566075d81" xlink:to="loc_rvnc_ProceedsFromIssuanceofFollowOnOffering_9b2ae8cb-8c23-47d9-667a-b51777eb7c88" xlink:type="arc"/>
<loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_8c608436-f07c-e907-aa0d-bfd819a80a12" xlink:type="locator"/>
<calculationArc order="10" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_a678c20d-a481-ef6a-800a-4bd566075d81" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_8c608436-f07c-e907-aa0d-bfd819a80a12" xlink:type="arc"/>
<loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_916e1eb7-21fa-e5f0-a15f-0b05ed633776" xlink:type="locator"/>
<calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_ff5db18e-7b91-5a5d-e914-0527b02a8012" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_916e1eb7-21fa-e5f0-a15f-0b05ed633776" xlink:type="arc"/>
<loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_e62ce8b8-4401-2622-8598-3e644745e95e" xlink:type="locator"/>
<calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_916e1eb7-21fa-e5f0-a15f-0b05ed633776" xlink:to="loc_us-gaap_NetIncomeLoss_e62ce8b8-4401-2622-8598-3e644745e95e" xlink:type="arc"/>
<loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaap_Depreciation_e89d82f5-1a55-1c1a-b859-e9f66fe37c08" xlink:type="locator"/>
<calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_916e1eb7-21fa-e5f0-a15f-0b05ed633776" xlink:to="loc_us-gaap_Depreciation_e89d82f5-1a55-1c1a-b859-e9f66fe37c08" xlink:type="arc"/>
<loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:label="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_3ef3660d-f952-6ded-6018-37f75b491ea0" xlink:type="locator"/>
<calculationArc order="3" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_916e1eb7-21fa-e5f0-a15f-0b05ed633776" xlink:to="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_3ef3660d-f952-6ded-6018-37f75b491ea0" xlink:type="arc"/>
<loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium" xlink:label="loc_us-gaap_AmortizationOfDebtDiscountPremium_dfec2b16-4a43-7264-ec3d-010772e15534" xlink:type="locator"/>
<calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_916e1eb7-21fa-e5f0-a15f-0b05ed633776" xlink:to="loc_us-gaap_AmortizationOfDebtDiscountPremium_dfec2b16-4a43-7264-ec3d-010772e15534" xlink:type="arc"/>
<loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AmortizationOfFinancingCosts" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_9b0336f3-1570-e518-771d-91dfd9dbbc96" xlink:type="locator"/>
<calculationArc order="5" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_916e1eb7-21fa-e5f0-a15f-0b05ed633776" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_9b0336f3-1570-e518-771d-91dfd9dbbc96" xlink:type="arc"/>
<loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="loc_us-gaap_FairValueAdjustmentOfWarrants_62790e96-2cfd-e84e-131c-ca4fa0c495e1" xlink:type="locator"/>
<calculationArc order="6" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_916e1eb7-21fa-e5f0-a15f-0b05ed633776" xlink:to="loc_us-gaap_FairValueAdjustmentOfWarrants_62790e96-2cfd-e84e-131c-ca4fa0c495e1" xlink:type="arc"/>
<loc xlink:href="rvnc-20150930.xsd#rvnc_RevaluationOfConvertibleRedeemablePreferredStockWarrants" xlink:label="loc_rvnc_RevaluationOfConvertibleRedeemablePreferredStockWarrants_e8c86b7f-c87c-f4c2-7ddd-b51777d5776e" xlink:type="locator"/>
<calculationArc order="7" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_916e1eb7-21fa-e5f0-a15f-0b05ed633776" xlink:to="loc_rvnc_RevaluationOfConvertibleRedeemablePreferredStockWarrants_e8c86b7f-c87c-f4c2-7ddd-b51777d5776e" xlink:type="arc"/>
<loc xlink:href="rvnc-20150930.xsd#rvnc_ExtinguishmentofWarrantLiabilityUponExerciseofPutOption" xlink:label="loc_rvnc_ExtinguishmentofWarrantLiabilityUponExerciseofPutOption_fcf2859f-f9f6-d7bf-cd72-b51777d06635" xlink:type="locator"/>
<calculationArc order="8" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_916e1eb7-21fa-e5f0-a15f-0b05ed633776" xlink:to="loc_rvnc_ExtinguishmentofWarrantLiabilityUponExerciseofPutOption_fcf2859f-f9f6-d7bf-cd72-b51777d06635" xlink:type="arc"/>
<loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_579a2a05-20b3-ca98-9d6b-7595046298be" xlink:type="locator"/>
<calculationArc order="9" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_916e1eb7-21fa-e5f0-a15f-0b05ed633776" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_579a2a05-20b3-ca98-9d6b-7595046298be" xlink:type="arc"/>
<loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaap_ShareBasedCompensation_d4c99b59-c44a-c4ac-309f-0bddfdb944a5" xlink:type="locator"/>
<calculationArc order="10" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_916e1eb7-21fa-e5f0-a15f-0b05ed633776" xlink:to="loc_us-gaap_ShareBasedCompensation_d4c99b59-c44a-c4ac-309f-0bddfdb944a5" xlink:type="arc"/>
<loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InterestExpenseDebt" xlink:label="loc_us-gaap_InterestExpenseDebt_303ddad1-c92e-dee8-e988-6fa7a693d02e" xlink:type="locator"/>
<calculationArc order="11" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_916e1eb7-21fa-e5f0-a15f-0b05ed633776" xlink:to="loc_us-gaap_InterestExpenseDebt_303ddad1-c92e-dee8-e988-6fa7a693d02e" xlink:type="arc"/>
<loc xlink:href="rvnc-20150930.xsd#rvnc_InterestExpenseCapitalized" xlink:label="loc_rvnc_InterestExpenseCapitalized_b43bc492-079b-96a1-b99a-b517782a7ae1" xlink:type="locator"/>
<calculationArc order="12" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_916e1eb7-21fa-e5f0-a15f-0b05ed633776" xlink:to="loc_rvnc_InterestExpenseCapitalized_b43bc492-079b-96a1-b99a-b517782a7ae1" xlink:type="arc"/>
<loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FinancingInterestExpense" xlink:label="loc_us-gaap_FinancingInterestExpense_48b7ad82-75d0-c1ec-dc17-abd4d266e501" xlink:type="locator"/>
<calculationArc order="13" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_916e1eb7-21fa-e5f0-a15f-0b05ed633776" xlink:to="loc_us-gaap_FinancingInterestExpense_48b7ad82-75d0-c1ec-dc17-abd4d266e501" xlink:type="arc"/>
<loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_466891d8-a228-268b-1fd8-1eca117e27a6" xlink:type="locator"/>
<calculationArc order="14" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_916e1eb7-21fa-e5f0-a15f-0b05ed633776" xlink:to="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_466891d8-a228-268b-1fd8-1eca117e27a6" xlink:type="arc"/>
<loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_709900d0-f7b0-b950-eae5-eeb8fc36b367" xlink:type="locator"/>
<calculationArc order="15" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_916e1eb7-21fa-e5f0-a15f-0b05ed633776" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_709900d0-f7b0-b950-eae5-eeb8fc36b367" xlink:type="arc"/>
<loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_a82e4d3f-eca5-47b9-3a4e-88f298c68036" xlink:type="locator"/>
<calculationArc order="16" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_916e1eb7-21fa-e5f0-a15f-0b05ed633776" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_a82e4d3f-eca5-47b9-3a4e-88f298c68036" xlink:type="arc"/>
<loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableTrade_8d552e1d-3ef1-9e76-644c-2357bedabbd5" xlink:type="locator"/>
<calculationArc order="17" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_916e1eb7-21fa-e5f0-a15f-0b05ed633776" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableTrade_8d552e1d-3ef1-9e76-644c-2357bedabbd5" xlink:type="arc"/>
<loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_1d5377b2-ec05-33fd-26fe-62d3fd26bc4d" xlink:type="locator"/>
<calculationArc order="18" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_916e1eb7-21fa-e5f0-a15f-0b05ed633776" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_1d5377b2-ec05-33fd-26fe-62d3fd26bc4d" xlink:type="arc"/>
<loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseDecreaseInDerivativeLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInDerivativeLiabilities_81fe2b0c-39cf-81a9-947a-eaab2f1b12fd" xlink:type="locator"/>
<calculationArc order="19" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_916e1eb7-21fa-e5f0-a15f-0b05ed633776" xlink:to="loc_us-gaap_IncreaseDecreaseInDerivativeLiabilities_81fe2b0c-39cf-81a9-947a-eaab2f1b12fd" xlink:type="arc"/>
<loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidRent" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidRent_dc864339-542d-c391-546a-104d0b118f12" xlink:type="locator"/>
<calculationArc order="20" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_916e1eb7-21fa-e5f0-a15f-0b05ed633776" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidRent_dc864339-542d-c391-546a-104d0b118f12" xlink:type="arc"/>
<loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_ccf69244-7aaf-19cf-90d6-269f163732c4" xlink:type="locator"/>
<calculationArc order="21" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_916e1eb7-21fa-e5f0-a15f-0b05ed633776" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_ccf69244-7aaf-19cf-90d6-269f163732c4" xlink:type="arc"/>
<loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_GainLossOnDerivativeInstrumentsNetPretax" xlink:label="loc_us-gaap_GainLossOnDerivativeInstrumentsNetPretax_aa1c1d3a-3c5f-1416-a988-644e94e86c05" xlink:type="locator"/>
<calculationArc order="22" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_916e1eb7-21fa-e5f0-a15f-0b05ed633776" xlink:to="loc_us-gaap_GainLossOnDerivativeInstrumentsNetPretax_aa1c1d3a-3c5f-1416-a988-644e94e86c05" xlink:type="arc"/>
<loc xlink:href="rvnc-20150930.xsd#rvnc_GainLossonDerivativeInstrumentsContractNetPretax" xlink:label="loc_rvnc_GainLossonDerivativeInstrumentsContractNetPretax_e1594837-02fc-96bc-26c9-b5177841c36c" xlink:type="locator"/>
<calculationArc order="23" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_916e1eb7-21fa-e5f0-a15f-0b05ed633776" xlink:to="loc_rvnc_GainLossonDerivativeInstrumentsContractNetPretax_e1594837-02fc-96bc-26c9-b5177841c36c" xlink:type="arc"/>
<loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_58a5bd26-e5f4-de8f-6118-f713733148b8" xlink:type="locator"/>
<calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_ff5db18e-7b91-5a5d-e914-0527b02a8012" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_58a5bd26-e5f4-de8f-6118-f713733148b8" xlink:type="arc"/>
<loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_386292ff-155c-0309-455a-2b91b395b3da" xlink:type="locator"/>
<calculationArc order="1" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_58a5bd26-e5f4-de8f-6118-f713733148b8" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_386292ff-155c-0309-455a-2b91b395b3da" xlink:type="arc"/>
<loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PaymentsToAcquireInvestments" xlink:label="loc_us-gaap_PaymentsToAcquireInvestments_0fe9734f-4949-ceed-023e-2a3ad290b409" xlink:type="locator"/>
<calculationArc order="2" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_58a5bd26-e5f4-de8f-6118-f713733148b8" xlink:to="loc_us-gaap_PaymentsToAcquireInvestments_0fe9734f-4949-ceed-023e-2a3ad290b409" xlink:type="arc"/>
<loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseDecreaseInRestrictedCash" xlink:label="loc_us-gaap_IncreaseDecreaseInRestrictedCash_8c9d9d5e-0593-ae0e-95c3-bce133b31671" xlink:type="locator"/>
<calculationArc order="3" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_58a5bd26-e5f4-de8f-6118-f713733148b8" xlink:to="loc_us-gaap_IncreaseDecreaseInRestrictedCash_8c9d9d5e-0593-ae0e-95c3-bce133b31671" xlink:type="arc"/>
</calculationLink>
<calculationLink xlink:role="http://www.revance.com/role/ConvertibleNotesWarrantsAndRelatedDerivatives" xlink:type="extended"/>
<calculationLink xlink:role="http://www.revance.com/role/ConvertibleNotesWarrantsAndRelatedDerivativesAdditionalInformationDetail" xlink:type="extended"/>
<calculationLink xlink:role="http://www.revance.com/role/DocumentAndEntityInformation" xlink:type="extended"/>
<calculationLink xlink:role="http://www.revance.com/role/Equity" xlink:type="extended"/>
<calculationLink xlink:role="http://www.revance.com/role/EquityAdditionalInformationDetail" xlink:type="extended"/>
<calculationLink xlink:role="http://www.revance.com/role/EquityFairValueAssumptionsDetails" xlink:type="extended"/>
<calculationLink xlink:role="http://www.revance.com/role/EquityScheduleOfAccumulatedOtherComprehensiveIncomeDetails" xlink:type="extended">
<loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_e716acb8-9d7f-1564-a267-c0491db420a5" xlink:type="locator"/>
<loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_639358e7-813a-36e9-6425-d461027b3e4b" xlink:type="locator"/>
<calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_e716acb8-9d7f-1564-a267-c0491db420a5" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_639358e7-813a-36e9-6425-d461027b3e4b" xlink:type="arc"/>
<loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_5abb52e6-6b1e-a39b-b008-b28e0b654b4f" xlink:type="locator"/>
<calculationArc order="2" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_e716acb8-9d7f-1564-a267-c0491db420a5" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_5abb52e6-6b1e-a39b-b008-b28e0b654b4f" xlink:type="arc"/>
</calculationLink>
<calculationLink xlink:role="http://www.revance.com/role/EquityScheduleOfStockBasedCompensationExpenseDetails" xlink:type="extended"/>
<calculationLink xlink:role="http://www.revance.com/role/EquityTables" xlink:type="extended"/>
<calculationLink xlink:role="http://www.revance.com/role/FairValueMeasurements" xlink:type="extended"/>
<calculationLink xlink:role="http://www.revance.com/role/FairValueMeasurementsScheduleOfFairValueOfFinancialInstrumentsDetail" xlink:type="extended"/>
<calculationLink xlink:role="http://www.revance.com/role/FairValueMeasurementsSummaryOfChangesInFairValueOfFinancialInstrumentsDetail" xlink:type="extended"/>
<calculationLink xlink:role="http://www.revance.com/role/FairValueMeasurementsTables" xlink:type="extended"/>
<calculationLink xlink:role="http://www.revance.com/role/InterestExpense" xlink:type="extended"/>
<calculationLink xlink:role="http://www.revance.com/role/InterestExpenseSummaryOfInterestExpenseByCashAndNonCashComponentsDetail" xlink:type="extended">
<loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaap_InterestExpense_8d3aa4ad-dbea-9eba-4578-5d3b83ba3bc6" xlink:type="locator"/>
<loc xlink:href="rvnc-20150930.xsd#rvnc_NoncashInterestExpense" xlink:label="loc_rvnc_NoncashInterestExpense_085c59f6-c973-ab04-0575-b5177820efe9" xlink:type="locator"/>
<calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InterestExpense_8d3aa4ad-dbea-9eba-4578-5d3b83ba3bc6" xlink:to="loc_rvnc_NoncashInterestExpense_085c59f6-c973-ab04-0575-b5177820efe9" xlink:type="arc"/>
<loc xlink:href="rvnc-20150930.xsd#rvnc_InterestExpenseDebtIssuanceCosts" xlink:label="loc_rvnc_InterestExpenseDebtIssuanceCosts_b3f0490c-ef2f-7ed8-01a0-b517781032f8" xlink:type="locator"/>
<calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_rvnc_NoncashInterestExpense_085c59f6-c973-ab04-0575-b5177820efe9" xlink:to="loc_rvnc_InterestExpenseDebtIssuanceCosts_b3f0490c-ef2f-7ed8-01a0-b517781032f8" xlink:type="arc"/>
<loc xlink:href="rvnc-20150930.xsd#rvnc_InterestExpenseWarrantandDerivativeRelatedDebtDiscounts" xlink:label="loc_rvnc_InterestExpenseWarrantandDerivativeRelatedDebtDiscounts_5e859334-2238-355e-33c4-b5177845a60d" xlink:type="locator"/>
<calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_rvnc_NoncashInterestExpense_085c59f6-c973-ab04-0575-b5177820efe9" xlink:to="loc_rvnc_InterestExpenseWarrantandDerivativeRelatedDebtDiscounts_5e859334-2238-355e-33c4-b5177845a60d" xlink:type="arc"/>
<loc xlink:href="rvnc-20150930.xsd#rvnc_InterestExpenseConvertibleNotes" xlink:label="loc_rvnc_InterestExpenseConvertibleNotes_3aec1f45-0279-2cce-f562-b517781cd0e0" xlink:type="locator"/>
<calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_rvnc_NoncashInterestExpense_085c59f6-c973-ab04-0575-b5177820efe9" xlink:to="loc_rvnc_InterestExpenseConvertibleNotes_3aec1f45-0279-2cce-f562-b517781cd0e0" xlink:type="arc"/>
<loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_579a2a05-20b3-ca98-9d6b-7595046298be" xlink:type="locator"/>
<calculationArc order="4" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_rvnc_NoncashInterestExpense_085c59f6-c973-ab04-0575-b5177820efe9" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_579a2a05-20b3-ca98-9d6b-7595046298be" xlink:type="arc"/>
<loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FinancingInterestExpense" xlink:label="loc_us-gaap_FinancingInterestExpense_48b7ad82-75d0-c1ec-dc17-abd4d266e501" xlink:type="locator"/>
<calculationArc order="5" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_rvnc_NoncashInterestExpense_085c59f6-c973-ab04-0575-b5177820efe9" xlink:to="loc_us-gaap_FinancingInterestExpense_48b7ad82-75d0-c1ec-dc17-abd4d266e501" xlink:type="arc"/>
<loc xlink:href="rvnc-20150930.xsd#rvnc_InterestExpenseCapitalized" xlink:label="loc_rvnc_InterestExpenseCapitalized_b43bc492-079b-96a1-b99a-b517782a7ae1" xlink:type="locator"/>
<calculationArc order="6" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_rvnc_NoncashInterestExpense_085c59f6-c973-ab04-0575-b5177820efe9" xlink:to="loc_rvnc_InterestExpenseCapitalized_b43bc492-079b-96a1-b99a-b517782a7ae1" xlink:type="arc"/>
<loc xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InterestExpenseDebtExcludingAmortization" xlink:label="loc_us-gaap_InterestExpenseDebtExcludingAmortization_245362ff-7e62-b383-e298-a09d22dc0e67" xlink:type="locator"/>
<calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InterestExpense_8d3aa4ad-dbea-9eba-4578-5d3b83ba3bc6" xlink:to="loc_us-gaap_InterestExpenseDebtExcludingAmortization_245362ff-7e62-b383-e298-a09d22dc0e67" xlink:type="arc"/>
</calculationLink>
<calculationLink xlink:role="http://www.revance.com/role/InterestExpenseTables" xlink:type="extended"/>
<calculationLink xlink:role="http://www.revance.com/role/MedicisSettlement" xlink:type="extended"/>
<calculationLink xlink:role="http://www.revance.com/role/MedicisSettlementAdditionalInformationDetail" xlink:type="extended"/>
<calculationLink xlink:role="http://www.revance.com/role/NetLossPerShareAttributableToCommonStockholders" xlink:type="extended"/>
<calculationLink xlink:role="http://www.revance.com/role/NetLossPerShareAttributableToCommonStockholdersScheduleOfComputationOfBasicAndDilutedNetIncomeLossPerShareAttributableToCommonStockholdersDetail" xlink:type="extended"/>
<calculationLink xlink:role="http://www.revance.com/role/NetLossPerShareAttributableToCommonStockholdersSummaryOfCommonStockEquivalentsExcludedFromComputationOfDilutedNetIncomeLossPerShareDetail" xlink:type="extended"/>
<calculationLink xlink:role="http://www.revance.com/role/NetLossPerShareAttributableToCommonStockholdersTables" xlink:type="extended"/>
<calculationLink xlink:role="http://www.revance.com/role/NotesPayableAndFinancingObligation" xlink:type="extended"/>
<calculationLink xlink:role="http://www.revance.com/role/NotesPayableAndFinancingObligationEssexCapitalNotesDetail" xlink:type="extended"/>
<calculationLink xlink:role="http://www.revance.com/role/NotesPayableAndFinancingObligationHerculesNotesPayableDetail" xlink:type="extended"/>
<calculationLink xlink:role="http://www.revance.com/role/NotesPayableAndFinancingObligationSummaryOfAggregateTotalFutureMinimumLeasePaymentsUnderFinancingObligationDetail" xlink:type="extended">
<loc xlink:href="rvnc-20150930.xsd#rvnc_FinancingObligationFutureMinimumPaymentsDue" xlink:label="loc_rvnc_FinancingObligationFutureMinimumPaymentsDue_3109378a-7d45-59f9-0e3b-b5177812b82a" xlink:type="locator"/>
<loc xlink:href="rvnc-20150930.xsd#rvnc_FinancingObligationFutureMinimumPaymentsNextTwelveMonths" xlink:label="loc_rvnc_FinancingObligationFutureMinimumPaymentsNextTwelveMonths_fff1f200-510a-ee84-c5ba-b51777d3b067" xlink:type="locator"/>
<calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_rvnc_FinancingObligationFutureMinimumPaymentsDue_3109378a-7d45-59f9-0e3b-b5177812b82a" xlink:to="loc_rvnc_FinancingObligationFutureMinimumPaymentsNextTwelveMonths_fff1f200-510a-ee84-c5ba-b51777d3b067" xlink:type="arc"/>
<loc xlink:href="rvnc-20150930.xsd#rvnc_FinancingObligationFutureMinimumPaymentsDueinTwoYears" xlink:label="loc_rvnc_FinancingObligationFutureMinimumPaymentsDueinTwoYears_ae01a4cf-c978-3aec-9557-b51777ce682a" xlink:type="locator"/>
<calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_rvnc_FinancingObligationFutureMinimumPaymentsDue_3109378a-7d45-59f9-0e3b-b5177812b82a" xlink:to="loc_rvnc_FinancingObligationFutureMinimumPaymentsDueinTwoYears_ae01a4cf-c978-3aec-9557-b51777ce682a" xlink:type="arc"/>
<loc xlink:href="rvnc-20150930.xsd#rvnc_FinancingObligationFutureMinimumPaymentsDueinThreeYears" xlink:label="loc_rvnc_FinancingObligationFutureMinimumPaymentsDueinThreeYears_5e8330ce-5d9a-dfb9-c471-b517782661d0" xlink:type="locator"/>
<calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_rvnc_FinancingObligationFutureMinimumPaymentsDue_3109378a-7d45-59f9-0e3b-b5177812b82a" xlink:to="loc_rvnc_FinancingObligationFutureMinimumPaymentsDueinThreeYears_5e8330ce-5d9a-dfb9-c471-b517782661d0" xlink:type="arc"/>
<loc xlink:href="rvnc-20150930.xsd#rvnc_FinancingObligationFutureMinimumPaymentsDueinFourYears" xlink:label="loc_rvnc_FinancingObligationFutureMinimumPaymentsDueinFourYears_9fe5c9e9-3fbf-9f70-f978-b51777d75eec" xlink:type="locator"/>
<calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_rvnc_FinancingObligationFutureMinimumPaymentsDue_3109378a-7d45-59f9-0e3b-b5177812b82a" xlink:to="loc_rvnc_FinancingObligationFutureMinimumPaymentsDueinFourYears_9fe5c9e9-3fbf-9f70-f978-b51777d75eec" xlink:type="arc"/>
</calculationLink>
<calculationLink xlink:role="http://www.revance.com/role/NotesPayableAndFinancingObligationTables" xlink:type="extended"/>
<calculationLink xlink:role="http://www.revance.com/role/SubsequentEvents" xlink:type="extended"/>
<calculationLink xlink:role="http://www.revance.com/role/SubsequentEventsDetails" xlink:type="extended"/>
<calculationLink xlink:role="http://www.revance.com/role/SummaryOfSignificantAccountingPolicies" xlink:type="extended"/>
<calculationLink xlink:role="http://www.revance.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="extended"/>
<calculationLink xlink:role="http://www.revance.com/role/Warrants" xlink:type="extended"/>
<calculationLink xlink:role="http://www.revance.com/role/WarrantsAdditionalInformationDetail" xlink:type="extended"/>
</linkbase>


8 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/29/24  Revance Therapeutics, Inc.        S-8         2/29/24    4:123K
 2/28/24  Revance Therapeutics, Inc.        10-K       12/31/23  110:12M
 2/28/23  Revance Therapeutics, Inc.        S-8         2/28/23    5:192K
 2/28/23  Revance Therapeutics, Inc.        10-K       12/31/22  109:14M
 2/28/22  Revance Therapeutics, Inc.        S-8         2/28/22    5:197K
 2/28/22  Revance Therapeutics, Inc.        10-K       12/31/21  106:12M
 2/25/21  Revance Therapeutics, Inc.        10-K       12/31/20  109:12M
 1/29/21  Revance Therapeutics, Inc.        S-8         1/29/21    3:137K
Top
Filing Submission 0001479290-15-000010   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Fri., Mar. 29, 6:30:51.1am ET